Australian women at elevated risk of breast cancer are under-utilising available risk-reducing medications (RRMed) such as tamoxifen and anastrozole. A study of 2,895 Australian women enrolled in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer cohort (kConFab) between 1997 and 2008 and eligible for RRMed found only 2.4% had ever taken one ...
‘Precision prevention’ effort required in breast cancer after study shows underuse of tamoxifen
By Mardi Chapman
2 Sep 2021